EA201691002A1 - Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гамма - Google Patents
Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гаммаInfo
- Publication number
- EA201691002A1 EA201691002A1 EA201691002A EA201691002A EA201691002A1 EA 201691002 A1 EA201691002 A1 EA 201691002A1 EA 201691002 A EA201691002 A EA 201691002A EA 201691002 A EA201691002 A EA 201691002A EA 201691002 A1 EA201691002 A1 EA 201691002A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- indoal
- heteroarrynal
- bicyclic
- rorγt
- ror gamma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Abstract
Изобретение относится к соединениям формулы (I) и его фармацевтически приемлемым солям, где X, X, М, R, R, R, R, m, n, и р определены в настоящем документе, которые являются активными в качестве модуляторов ретиноид-родственного сиротского рецептора гамма t (RORγt). Данные соединения предотвращают, ингибируют или подавляют действие RORγt, и таким образом подходят для лечения заболеваний, расстройств, синдромов или состояний, опосредованных RORγt, таких как, например, боль, воспаление, ХОБЛ, астма, ревматоидный артрит, колит, множественный склероз, нейродегенеративные заболевания и рак.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN3853MU2013 | 2013-12-10 | ||
IN527MU2014 | 2014-02-14 | ||
IN2172MU2014 | 2014-07-04 | ||
PCT/IB2014/066720 WO2015087234A1 (en) | 2013-12-10 | 2014-12-09 | Bicyclic heteroaryl indole analogues useful as ror gamma modulators |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201691002A1 true EA201691002A1 (ru) | 2016-12-30 |
EA029489B1 EA029489B1 (ru) | 2018-04-30 |
Family
ID=52355020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201691002A EA029489B1 (ru) | 2013-12-10 | 2014-12-09 | Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гамма |
Country Status (18)
Country | Link |
---|---|
US (1) | US9682977B2 (ru) |
EP (1) | EP3080090B1 (ru) |
JP (1) | JP2016539989A (ru) |
CN (1) | CN105980364A (ru) |
AP (1) | AP2016009281A0 (ru) |
AU (1) | AU2014363035A1 (ru) |
BR (1) | BR112016013425A2 (ru) |
CA (1) | CA2933003A1 (ru) |
CL (1) | CL2016001441A1 (ru) |
EA (1) | EA029489B1 (ru) |
IL (1) | IL246123A0 (ru) |
MX (1) | MX2016007604A (ru) |
PE (1) | PE20160687A1 (ru) |
PH (1) | PH12016501105A1 (ru) |
SG (1) | SG11201604714SA (ru) |
TW (1) | TW201605797A (ru) |
WO (1) | WO2015087234A1 (ru) |
ZA (1) | ZA201604454B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201419015D0 (en) | 2014-10-24 | 2014-12-10 | Orca Pharmaceuticals Ltd | Compounds |
EP3256450B1 (en) | 2015-02-11 | 2020-12-02 | Merck Sharp & Dohme Corp. | Substituted pyrazole compounds as ror-gamma-t inhibitors and uses thereof |
WO2017051319A1 (en) * | 2015-09-21 | 2017-03-30 | Glenmark Pharmaceuticals S.A. | Aryl and heteroaryl ether compounds as ror gamma modulators |
EP3368516B1 (en) * | 2015-10-27 | 2020-07-15 | Merck Sharp & Dohme Corp. | SUBSTITUTED BICYCLIC PYRAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF |
US10584121B2 (en) | 2015-10-27 | 2020-03-10 | Merck Sharp & Dohme Corp. | Heteroaryl substituted benzoic acids as RORgammaT inhibitors and uses thereof |
KR20180070697A (ko) | 2015-10-27 | 2018-06-26 | 머크 샤프 앤드 돔 코포레이션 | Ror감마t 저해제로서의 치환된 인다졸 화합물 및 이의 용도 |
WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
AR110481A1 (es) | 2016-12-05 | 2019-04-03 | Lead Pharma Holding Bv | MODULADORES DE ROR g (RORg) |
TW201906816A (zh) * | 2017-07-06 | 2019-02-16 | 大陸商江蘇恆瑞醫藥股份有限公司 | 吲哚甲醯胺類衍生物、其製備方法及其在醫藥上的應用 |
EP3663299B1 (en) * | 2017-08-01 | 2023-03-08 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Bicyclic compound acting as ror gamma inhibitor |
WO2019100106A1 (en) * | 2017-11-24 | 2019-05-31 | The University Of Sydney | Antibacterial compounds and methods of use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200621237A (en) | 2004-11-01 | 2006-07-01 | Wyeth Corp | [(1-h-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1h-indazol-3-yl)methanones |
WO2006075638A1 (ja) * | 2005-01-14 | 2006-07-20 | Dainippon Sumitomo Pharma Co., Ltd. | 新規ヘテロアリール誘導体 |
CN103201262B (zh) * | 2010-08-20 | 2016-06-01 | 艾米拉医药股份有限公司 | 自分泌运动因子抑制剂及其用途 |
WO2012027965A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
WO2012028100A1 (en) | 2010-09-01 | 2012-03-08 | Glaxo Group Limited | Novel compounds |
US9512111B2 (en) * | 2010-11-08 | 2016-12-06 | Lycera Corporation | N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease |
WO2012100734A1 (en) | 2011-01-24 | 2012-08-02 | Glaxo Group Limited | Compounds useful as retinoid-related orphan receptor gamma modulators |
WO2012100732A1 (en) | 2011-01-24 | 2012-08-02 | Glaxo Group Limited | Retinoid-related orphan receptor gamma modulators, composition containing them and uses thereof |
EP2487159A1 (en) * | 2011-02-11 | 2012-08-15 | MSD Oss B.V. | RorgammaT inhibitors |
EP2511263A1 (en) | 2011-04-14 | 2012-10-17 | Phenex Pharmaceuticals AG | Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
WO2013171729A2 (en) | 2013-01-08 | 2013-11-21 | Glenmark Pharmaceuticals S.A. | Aryl and heteroaryl amide compounds as rorgamat modulator |
-
2014
- 2014-11-26 TW TW103140995A patent/TW201605797A/zh unknown
- 2014-12-09 EA EA201691002A patent/EA029489B1/ru not_active IP Right Cessation
- 2014-12-09 EP EP14827867.4A patent/EP3080090B1/en not_active Not-in-force
- 2014-12-09 WO PCT/IB2014/066720 patent/WO2015087234A1/en active Application Filing
- 2014-12-09 US US15/103,658 patent/US9682977B2/en not_active Expired - Fee Related
- 2014-12-09 MX MX2016007604A patent/MX2016007604A/es unknown
- 2014-12-09 PE PE2016000783A patent/PE20160687A1/es not_active Application Discontinuation
- 2014-12-09 JP JP2016538031A patent/JP2016539989A/ja active Pending
- 2014-12-09 AU AU2014363035A patent/AU2014363035A1/en not_active Abandoned
- 2014-12-09 CA CA2933003A patent/CA2933003A1/en not_active Abandoned
- 2014-12-09 SG SG11201604714SA patent/SG11201604714SA/en unknown
- 2014-12-09 BR BR112016013425A patent/BR112016013425A2/pt active Search and Examination
- 2014-12-09 CN CN201480074962.XA patent/CN105980364A/zh active Pending
- 2014-12-09 AP AP2016009281A patent/AP2016009281A0/en unknown
-
2016
- 2016-06-08 IL IL246123A patent/IL246123A0/en unknown
- 2016-06-09 PH PH12016501105A patent/PH12016501105A1/en unknown
- 2016-06-10 CL CL2016001441A patent/CL2016001441A1/es unknown
- 2016-06-10 ZA ZA2016/04454A patent/ZA201604454B/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12016501105A1 (en) | 2016-07-11 |
US20160326163A1 (en) | 2016-11-10 |
CA2933003A1 (en) | 2015-06-18 |
BR112016013425A2 (pt) | 2017-08-08 |
EP3080090B1 (en) | 2018-01-31 |
IL246123A0 (en) | 2016-08-02 |
WO2015087234A1 (en) | 2015-06-18 |
ZA201604454B (en) | 2017-11-29 |
AP2016009281A0 (en) | 2016-06-30 |
EA029489B1 (ru) | 2018-04-30 |
US9682977B2 (en) | 2017-06-20 |
JP2016539989A (ja) | 2016-12-22 |
AU2014363035A1 (en) | 2016-06-30 |
SG11201604714SA (en) | 2016-07-28 |
MX2016007604A (es) | 2017-02-28 |
EP3080090A1 (en) | 2016-10-19 |
CL2016001441A1 (es) | 2017-03-03 |
TW201605797A (zh) | 2016-02-16 |
CN105980364A (zh) | 2016-09-28 |
PE20160687A1 (es) | 2016-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201691002A1 (ru) | Бициклические гетероарильные аналоги индола, подходящие в качестве модуляторов ror гамма | |
PH12016502045A1 (en) | Aryl and heteroaryl ether compounds as ror gamma modulators | |
EA201890072A1 (ru) | Новые соединения в качестве модуляторов ror-гамма | |
CY1121850T1 (el) | Διαρυλο μακροκυκλοι ως ρυθμιστες των πρωτεϊνικων kinασων | |
WO2013171729A3 (en) | Aryl and heteroaryl amide compounds as ror gamma t modulator | |
CL2016001579A1 (es) | Nuevas indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen, así como su uso para la preparación de medicamentos. | |
EA201792515A1 (ru) | ЗАМЕЩЕННЫЕ СОЕДИНЕНИЯ ТЕТРАГИДРОХИНОЛИНОНА В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕТИНОИДНЫХ ОРФАНОВЫХ РЕЦЕПТОРОВ ГАММА (RORγ) | |
DOP2016000094A (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4. | |
EA201890052A1 (ru) | Регуляторы nrf2 | |
EA201592143A1 (ru) | Новые бициклические ингибиторы бромодомена | |
EA201790528A1 (ru) | Дигидропирролопиридиновые ингибиторы ror-гамма | |
DOP2018000008A (es) | Inhibidores del receptor del factor estimulador de colonias 1 (csf-1r) | |
EA201791293A1 (ru) | Сайт-специфическое дозирование ингибитора btk | |
MY193715A (en) | Nuclear receptor modulators (ror) for the treatment of inflammatory and autoimmune diseases | |
MX2017015737A (es) | Moduladores de ror gamma (ror?). | |
EA201790519A1 (ru) | Терапевтические соединения в качестве ингибиторов рецептора орексина-1 | |
EA201790949A1 (ru) | Замещенные 2,4-диаминохинолины в качестве новых противораковых средств | |
MX2018008454A (es) | Derivado de amina ciclica y uso medico del mismo. | |
EA201791600A1 (ru) | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора | |
CL2017002405A1 (es) | Compuestos bicíclicos fusionados, composición farmacéutica que los comprende y su uso para el tratamiento de enfermedades o desordenes relacionados con el fxr. | |
AU2015278731B2 (en) | Fused triterpene compounds and uses thereof | |
PH12016501393A1 (en) | Substituted bicyclic heteroaryl compounds as rxr agonists | |
CL2016002321A1 (es) | Compuestos derivados del ácido 2-8-5-cloropirimidin-2-ilamino-6,7,8,9-tetrahidro-5h-pirido3,2-bindol-5-ilacético, moduladores del receptor de prostaglandina d2 composición farmacéutica y su uso para el tratamiento de enfermedadestrastornos alérgicosinmunitarios. | |
PH12018500411A1 (en) | Novel carbocyclic compounds as ror gamma modulators | |
BR112016024749A2 (pt) | composto, composição farmacêutica, e, método de tratamento de câncer, de um distúrbio inflamatório, de um distúrbio de autoimunidade ou de um distúrbio neurodegenerativo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |